|

Metreleptin Clinical Trials

2 actively recruiting trials

Also known as: Myalept®

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Gabriella Milos1
  • Amryt Pharma1

Indications

  • Generalized Lipodystrophy1
  • Anorexia Nervosa1
  • Depression1
  • Diabetes1

Other2 trials

Metreleptin in Anorexia Nervosa
Phase 2
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.